Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

Completed · Phase 4

Conditions studied: Inflammation

In brief

A pilot study to evaluate the extent of PGE2 inhibition (mean aqueous values) by Ketorolac 0.04% following peripheral iridotomy

Key facts

Study ID

NCT00791323

Run by

Allergan

People needed

9

Starts

2008-11-01

Expected to finish

2009-08-01

Last updated by the study team

2011-09-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled to undergo phakic IOL implantation

You may not qualify if…

• History of intraocular surgery in the operative eye

Where it is running

• Study site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.